Cargando…
Metastatic urothelial carcinoma to the liver with unknown primary tumor
Cancer of unknown primary (CUP), a rare and aggressive clinical entity, accounts for approximately 3% of all malignancies. CUP with urothelial origin is even more unusual, with no other cases reported in the current literature. As imaging and other studies often do not reveal the tumor origin, the a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704036/ https://www.ncbi.nlm.nih.gov/pubmed/31453109 http://dx.doi.org/10.1016/j.eucr.2019.100993 |
_version_ | 1783445421411008512 |
---|---|
author | Cheung, Carling Zhang, Li Clifton, Marisa M. Park, Alyssa Meissner, Matthew Fulmer, Brant R. |
author_facet | Cheung, Carling Zhang, Li Clifton, Marisa M. Park, Alyssa Meissner, Matthew Fulmer, Brant R. |
author_sort | Cheung, Carling |
collection | PubMed |
description | Cancer of unknown primary (CUP), a rare and aggressive clinical entity, accounts for approximately 3% of all malignancies. CUP with urothelial origin is even more unusual, with no other cases reported in the current literature. As imaging and other studies often do not reveal the tumor origin, the approach to CUP involves a focused search for the primary tumor, relying on guidance from immunohistochemical staining of biopsy specimens. Treatment consists of standard therapies directed at the most likely tumor origin. |
format | Online Article Text |
id | pubmed-6704036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67040362019-08-26 Metastatic urothelial carcinoma to the liver with unknown primary tumor Cheung, Carling Zhang, Li Clifton, Marisa M. Park, Alyssa Meissner, Matthew Fulmer, Brant R. Urol Case Rep Oncology Cancer of unknown primary (CUP), a rare and aggressive clinical entity, accounts for approximately 3% of all malignancies. CUP with urothelial origin is even more unusual, with no other cases reported in the current literature. As imaging and other studies often do not reveal the tumor origin, the approach to CUP involves a focused search for the primary tumor, relying on guidance from immunohistochemical staining of biopsy specimens. Treatment consists of standard therapies directed at the most likely tumor origin. Elsevier 2019-08-10 /pmc/articles/PMC6704036/ /pubmed/31453109 http://dx.doi.org/10.1016/j.eucr.2019.100993 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Oncology Cheung, Carling Zhang, Li Clifton, Marisa M. Park, Alyssa Meissner, Matthew Fulmer, Brant R. Metastatic urothelial carcinoma to the liver with unknown primary tumor |
title | Metastatic urothelial carcinoma to the liver with unknown primary tumor |
title_full | Metastatic urothelial carcinoma to the liver with unknown primary tumor |
title_fullStr | Metastatic urothelial carcinoma to the liver with unknown primary tumor |
title_full_unstemmed | Metastatic urothelial carcinoma to the liver with unknown primary tumor |
title_short | Metastatic urothelial carcinoma to the liver with unknown primary tumor |
title_sort | metastatic urothelial carcinoma to the liver with unknown primary tumor |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704036/ https://www.ncbi.nlm.nih.gov/pubmed/31453109 http://dx.doi.org/10.1016/j.eucr.2019.100993 |
work_keys_str_mv | AT cheungcarling metastaticurothelialcarcinomatotheliverwithunknownprimarytumor AT zhangli metastaticurothelialcarcinomatotheliverwithunknownprimarytumor AT cliftonmarisam metastaticurothelialcarcinomatotheliverwithunknownprimarytumor AT parkalyssa metastaticurothelialcarcinomatotheliverwithunknownprimarytumor AT meissnermatthew metastaticurothelialcarcinomatotheliverwithunknownprimarytumor AT fulmerbrantr metastaticurothelialcarcinomatotheliverwithunknownprimarytumor |